LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 35.77 | 21.74 | 934 | 2602 | 0.3588 | 0.7241 | MN20160310_N01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 37.74 | 21.74 | 68 | 2828 | 0.0240 | 0.1763 | MN20160310_N01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 37.74 | 21.74 | 753 | 2828 | 0.2662 | 0.6565 | MN20160310_N01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 37.74 | 21.74 | 10 | 2828 | 0.0035 | -0.1047 | MN20160310_N01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 37.74 | 21.74 | 915 | 2828 | 0.3235 | 0.7031 | MN20160310_N01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 39.71 | 21.74 | 52 | 3084 | 0.0169 | 0.1298 | MN20160310_N01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 39.71 | 21.74 | 742 | 3084 | 0.2406 | 0.6386 | MN20160310_N01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 39.71 | 21.74 | 7 | 3084 | 0.0023 | -0.1466 | MN20160310_N01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 39.71 | 21.74 | 908 | 3084 | 0.2944 | 0.6856 | MN20160310_N01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 41.68 | 21.74 | 74 | 3418 | 0.0216 | 0.1828 | MN20160310_N01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 41.68 | 21.74 | 745 | 3418 | 0.2179 | 0.6231 | MN20160310_N01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 41.68 | 21.74 | 9 | 3418 | 0.0026 | -0.1138 | MN20160310_N01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 41.68 | 21.74 | 904 | 3418 | 0.2644 | 0.6667 | MN20160310_N01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 43.65 | 21.74 | 82 | 3754 | 0.0218 | 0.1956 | MN20160310_N01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 43.65 | 21.74 | 738 | 3754 | 0.1966 | 0.6068 | MN20160310_N01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 43.65 | 21.74 | 12 | 3754 | 0.0032 | -0.0768 | MN20160310_N01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 43.65 | 21.74 | 898 | 3754 | 0.2392 | 0.6498 | MN20160310_N01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 45.62 | 21.74 | 90 | 4150 | 0.0217 | 0.2062 | MN20160310_N01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 45.62 | 21.74 | 736 | 4150 | 0.1773 | 0.5918 | MN20160310_N01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 45.62 | 21.74 | 8 | 4150 | 0.0019 | -0.1236 | MN20160310_N01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 45.62 | 21.74 | 884 | 4150 | 0.2130 | 0.6307 | MN20160310_N01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 47.59 | 21.74 | 79 | 4492 | 0.0176 | 0.1827 | MN20160310_N01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 47.59 | 21.74 | 734 | 4492 | 0.1634 | 0.5803 | MN20160310_N01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 47.59 | 21.74 | 5 | 4492 | 0.0011 | -0.1740 | MN20160310_N01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 47.59 | 21.74 | 864 | 4492 | 0.1923 | 0.6141 | MN20160310_N01 | K20 |